russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLC10.15829/1560-4071-2022-4994russjcardiol-4994Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWКардиомиопатия такоцубо. Обзор данных литературы: клиническая картина, алгоритм диагностики, лечение, прогноз. Часть IITakotsubo cardiomyopathy. Literature review: clinical performance, diagnostic algorithm, treatment, prognosis. Part IIhttps://orcid.org/0000-0002-1898-084XБолдуеваС. А.BolduevaS. A.

Светлана Афанасьевна Болдуева — доктор медицинских наук, профессор, зав. кафедрой факультетской терапии.

Санкт-Петербург

St. Petersburg

svetlanaboldueva@mail.ruhttps://orcid.org/0000-0002-3107-1691ЕвдокимовД. С.EvdokimovD. S.

Дмитрий Сергеевич Евдокимов — аспирант кафедры факультетской терапии.

Санкт-Петербург

St. Petersburg

kasabian244@gmail.comФГБОУ ВО Северо-Западный государственный медицинский университет им. И.И. МечниковаРоссияI.I. Mechnikov North-Western State Medical UniversityRussian Federation202213092022273SОбразование49944994Copyright © Болдуева С.А., Евдокимов Д.С., 20222022Болдуева С.А., Евдокимов Д.С.Boldueva S.A., Evdokimov D.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/4994

В обзоре представлены современные данные по проблеме кардиомиопатии такоцубо: информация о клинических проявлениях заболевания, алгоритме обследования и подходах к лечению, а также возможных осложнениях и прогнозе.

Up-to-date data on the problem of takotsubo cardiomyopathy, including data on the clinical manifestations, diagnostic algorithm and treatment approaches, as well as the prognosis of possible complications is presented in review.

кардиомиопатия такоцубоалгоритм диагностикиосложнения заболеваниялечениепрогнозtakotsubo syndromealgorithm of diagnosiscomplications of the diseasetreatmentprognosisReferencesTemplin C, Ghadri JR, Diekmann J, et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N. Engl. J. Med. 2015;373:929-38. doi:10.1056/NEJMoa1406761.Templin C, Ghadri JR, Diekmann J, et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N. Engl. J. Med. 2015;373:929-38. doi:10.1056/NEJMoa1406761.Ghadri JR, Cammann VL, Jurisic S, et al. A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. Eur J Heart Fail. 2017;19(8):1036-42. doi:10.1002/ejhf.683.Ghadri JR, Cammann VL, Jurisic S, et al. A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. Eur J Heart Fail. 2017;19(8):1036-42. doi:10.1002/ejhf.683.Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur. Heart J. 2018;39:2032-46. doi:10.1093/eurheartj/ehy076.Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur. Heart J. 2018;39:2032-46. doi:10.1093/eurheartj/ehy076.Núñez G, Andrés M, Almendro Delia M, et al. Characterization of Tako-tsubo Cardiomyopathy in Spain: Results from the RETAKO National Registry. Rev Esp Cardiol (Engl Ed). 2015;68(6):505-12. doi:10.1016/j.rec.2014.07.026.Núñez G, Andrés M, Almendro Delia M, et al. Characterization of Tako-tsubo Cardiomyopathy in Spain: Results from the RETAKO National Registry. Rev Esp Cardiol (Engl Ed). 2015;68(6):505-12. doi:10.1016/j.rec.2014.07.026.Rawish E, Stiermaier T, Santoro F, et al. Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1-Pathophysiology and Diagnosis. J Clin Med. 2021;10(3):479. doi:10.3390/jcm10030479.Rawish E, Stiermaier T, Santoro F, et al. Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1-Pathophysiology and Diagnosis. J Clin Med. 2021;10(3):479. doi:10.3390/jcm10030479.Santoro F, Brunetti ND, Tarantino N, et al. Dynamic changes of QTc interval and prognostic significance in takotsubo (stress) cardiomyopathy. Clin. Cardiol. 2017;40:1116-22. doi:10.1002/clc.22798.Santoro F, Brunetti ND, Tarantino N, et al. Dynamic changes of QTc interval and prognostic significance in takotsubo (stress) cardiomyopathy. Clin. Cardiol. 2017;40:1116-22. doi:10.1002/clc.22798.Namgung J. Electrocardiographic Findings in Takotsubo Cardiomyopathy: ECG Evolution and Its Difference from the ECG of Acute Coronary Syndrome. Clin. Med. Insights Cardiol. 2014;8:29-34. doi:10.4137/CMC.S14086.Namgung J. Electrocardiographic Findings in Takotsubo Cardiomyopathy: ECG Evolution and Its Difference from the ECG of Acute Coronary Syndrome. Clin. Med. Insights Cardiol. 2014;8:29-34. doi:10.4137/CMC.S14086.Kurisu S, Inoue I, Kawagoe T, et al. Time course of electrocardiographic changes in patients with tako-tsubo syndrome: Comparison with acute myocardial infarction with minimal enzymatic release. Circ. J. Off. J. Jpn. Circ. Soc. 2004;68:77-81. doi:10.1253/circj.68.77.Kurisu S, Inoue I, Kawagoe T, et al. Time course of electrocardiographic changes in patients with tako-tsubo syndrome: Comparison with acute myocardial infarction with minimal enzymatic release. Circ. J. Off. J. Jpn. Circ. Soc. 2004;68:77-81. doi:10.1253/circj.68.77.Frangieh AH, Obeid S, Ghadri JR, et al. ECG Criteria to Differentiate Between Takotsubo (Stress) Cardiomyopathy and Myocardial Infarction. J. Am. Heart Assoc. 2016;5:e003418. doi:10.1161/JAHA.116.003418.Frangieh AH, Obeid S, Ghadri JR, et al. ECG Criteria to Differentiate Between Takotsubo (Stress) Cardiomyopathy and Myocardial Infarction. J. Am. Heart Assoc. 2016;5:e003418. doi:10.1161/JAHA.116.003418.Tarantino N, Santoro F, Guastafierro F, et al. "Lambda-wave" ST-elevation is associated with severe prognosis in stress (takotsubo) cardiomyopathy. Ann Noninvasive Electrocardiol. 2018;23(6):e12581. doi:10.1111/anec.12581.Tarantino N, Santoro F, Guastafierro F, et al. "Lambda-wave" ST-elevation is associated with severe prognosis in stress (takotsubo) cardiomyopathy. Ann Noninvasive Electrocardiol. 2018;23(6):e12581. doi:10.1111/anec.12581.Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management. Eur Heart J. 2018;39(22):2047-62. doi:10.1093/eurheartj/ehy077.Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management. Eur Heart J. 2018;39(22):2047-62. doi:10.1093/eurheartj/ehy077.Çatalkaya DS, Demir E, Çatalkaya S. Electrocardiographic and Seasonal Patterns Allow Accurate Differentiation of Tako-Tsubo Cardiomyopathy from Acute Anterior Myocardial Infarction: Results of a Multicenter Study and Systematic Overview of Available Studies. Biomolecules. 2019;9(2):51. doi:10.3390/biom9020051.Çatalkaya DS, Demir E, Çatalkaya S. Electrocardiographic and Seasonal Patterns Allow Accurate Differentiation of Tako-Tsubo Cardiomyopathy from Acute Anterior Myocardial Infarction: Results of a Multicenter Study and Systematic Overview of Available Studies. Biomolecules. 2019;9(2):51. doi:10.3390/biom9020051.Santoro F, Stiermaier T, Tarantino N, et al. Impact of persistent ST elevation on outcome in patients with Takotsubo syndrome. Results from the GErman Italian STress Cardiomyopathy (GEIST) registry. Int. J. Cardiol. 2018;255:140-4. doi:10.1016/j.ijcard.2017.11.068.Santoro F, Stiermaier T, Tarantino N, et al. Impact of persistent ST elevation on outcome in patients with Takotsubo syndrome. Results from the GErman Italian STress Cardiomyopathy (GEIST) registry. Int. J. Cardiol. 2018;255:140-4. doi:10.1016/j.ijcard.2017.11.068.Madias JE. Electrocardiogram features and course in patients with takotsubo syndrome. Int J Cardiol. 2021;324:22. doi:10.1016/j.ijcard.2020.08.053.Madias JE. Electrocardiogram features and course in patients with takotsubo syndrome. Int J Cardiol. 2021;324:22. doi:10.1016/j.ijcard.2020.08.053.Kosuge M, Ebina T, Hibi K, et al. Differences in negative T waves between takotsubo cardiomyopathy and reperfused anterior acute myocardial infarction. Circ J. 2012;76(2):462-8. doi:10.1253/circj.cj-11-1036.Kosuge M, Ebina T, Hibi K, et al. Differences in negative T waves between takotsubo cardiomyopathy and reperfused anterior acute myocardial infarction. Circ J. 2012;76(2):462-8. doi:10.1253/circj.cj-11-1036.Pelliccia F, Parodi G, Greco C, et al. Comorbidities frequency in Takotsubo syndrome: An international collaborative systematic review including 1109 patients. Am. J. Med. 2015;128:654. doi:10.1016/j.amjmed.2015.01.016.Pelliccia F, Parodi G, Greco C, et al. Comorbidities frequency in Takotsubo syndrome: An international collaborative systematic review including 1109 patients. Am. J. Med. 2015;128:654. doi:10.1016/j.amjmed.2015.01.016.Мазнев Д.С., Болдуева С.А., Задворьев С.Ф. и др. Синдром такоцубо в сочетании с инфарктом миокарда 2-го типа у пациентки пожилого возраста с коронавирусной инфекцией. Профилактическая медицина. 2021;24(11):80-6. doi:10.17116/profmed20212411180.Maznev DS, Boldueva SA, Zadvoriev SF, et al. Takotsubo syndrome combined with myocardial infarction type 2 in an elderly patient with coronavirus infection. Profilakticheskaya Meditsina. 2021;24(11):80-6. (In Russ.) doi:10.17116/profmed20212411180.Giustino G, Croft LB, Oates CP, et al. Takotsubo Cardiomyopathy in COVID-19. J Am Coll Cardiol. 2020;76(5):628-9. doi:10.1016/j.jacc.2020.05.068.Giustino G, Croft LB, Oates CP, et al. Takotsubo Cardiomyopathy in COVID-19. J Am Coll Cardiol. 2020;76(5):628-9. doi:10.1016/j.jacc.2020.05.068.Surikow SY, Nguyen TH, Stafford I, et al. Nitrosative Stress as a Modulator of Inflammatory Change in a Model of Takotsubo Syndrome. JACC Basic Transl Sci. 2018;3(2):213-26. doi:10.1016/j.jacbts.2017.10.002.Surikow SY, Nguyen TH, Stafford I, et al. Nitrosative Stress as a Modulator of Inflammatory Change in a Model of Takotsubo Syndrome. JACC Basic Transl Sci. 2018;3(2):213-26. doi:10.1016/j.jacbts.2017.10.002.Dagrenat C, Von Hunolstein JJ, Matsushita K, et al. Value of Cardiac Biomarkers in the Early Diagnosis of Takotsubo Syndrome. J. Clin. Med. 2020;9:2985. doi:10.3390/jcm9092985.Dagrenat C, Von Hunolstein JJ, Matsushita K, et al. Value of Cardiac Biomarkers in the Early Diagnosis of Takotsubo Syndrome. J. Clin. Med. 2020;9:2985. doi:10.3390/jcm9092985.Gopalakrishnan P, Zaidi R, Sardar MR. Takotsubo cardiomyopathy: Pathophysiology and role of cardiac biomarkers in differential diagnosis. World J. Cardiol. 2017;9:723-30. doi:10.4330/wjc.v9.i9.723.Gopalakrishnan P, Zaidi R, Sardar MR. Takotsubo cardiomyopathy: Pathophysiology and role of cardiac biomarkers in differential diagnosis. World J. Cardiol. 2017;9:723-30. doi:10.4330/wjc.v9.i9.723.Budnik M, Białek S, Peller M, et al. Serum copeptin and copeptin/NT-proBNP ratio — new tools to differentiate takotsubo syndrome from acute myocardial infarction. Folia Med. Crac. 2020;60:5-14. doi:10.24425/fmc.2020.133481.Budnik M, Białek S, Peller M, et al. Serum copeptin and copeptin/NT-proBNP ratio — new tools to differentiate takotsubo syndrome from acute myocardial infarction. Folia Med. Crac. 2020;60:5-14. doi:10.24425/fmc.2020.133481.Santoro F, Costantino MD, Guastafierro F, et al. Inflammatory patterns in Takotsubo cardiomyopathy and acute coronary syndrome: A propensity score matched analysis. Atherosclerosis. 2018;274:157-61. doi:10.1016/j.atherosclerosis.2018.05.017.Santoro F, Costantino MD, Guastafierro F, et al. Inflammatory patterns in Takotsubo cardiomyopathy and acute coronary syndrome: A propensity score matched analysis. Atherosclerosis. 2018;274:157-61. doi:10.1016/j.atherosclerosis.2018.05.017.Citro R, Okura H, Ghadri JR, et al. Multimodality imaging in takotsubo syndrome: A joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE) J. Echocardiogr. 2020;18:199-224. doi:10.1007/s12574-020-00480-y.Citro R, Okura H, Ghadri JR, et al. Multimodality imaging in takotsubo syndrome: A joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE) J. Echocardiogr. 2020;18:199-224. doi:10.1007/s12574-020-00480-y.Napp LC, Cammann VL, Jaguszewski M, et al. Coexistence and outcome of coronary artery disease in Takotsubo syndrome. Eur. Heart J. 2020;41:3255-68. doi:10.1093/eurheartj/ehaa210.Napp LC, Cammann VL, Jaguszewski M, et al. Coexistence and outcome of coronary artery disease in Takotsubo syndrome. Eur. Heart J. 2020;41:3255-68. doi:10.1093/eurheartj/ehaa210.Болдуева С.А., Феоктистова В.С. Инфаркт миокарда без обструктивного атеросклеротического поражения коронарных артерий. Обзор данных литературы (часть II): клинические формы, алгоритм диагностики, лечение. Неотложная кардиология. 2019;3-4:15-31. doi:10.25679/EMERGCARDIOLOGY.2020.55.68.002.Boldueva SA, Feoktistova VS. Myocardial infarction with no obstructive coronary atherosclerosis (MINOCA): review (part 2). Clinical forms, diagnostic algorithm, treatment. Emergency Cardiology. 2019;3-4:15-31. (In Russ.) doi:10.25679/EMERGCARDIOLOGY.2020.55.68.002.Occhipinti G, Bucciarelli-Ducci C, Capodanno D. Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA). Eur Heart J Acute Cardiovasc Care. 2021;10(7):813-22. doi:10.1093/ehjacc/zuab049.Occhipinti G, Bucciarelli-Ducci C, Capodanno D. Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA). Eur Heart J Acute Cardiovasc Care. 2021;10(7):813-22. doi:10.1093/ehjacc/zuab049.Desmet W, Bennett J, Ferdinande B, et al. The apical nipple sign: A useful tool for discriminating between anterior infarction and transient left ventricular ballooning syndrome. Eur. Heart J. Acute Cardiovasc. Care. 2013;3:264-7. doi:10.1177/2048872613517359.Desmet W, Bennett J, Ferdinande B, et al. The apical nipple sign: A useful tool for discriminating between anterior infarction and transient left ventricular ballooning syndrome. Eur. Heart J. Acute Cardiovasc. Care. 2013;3:264-7. doi:10.1177/2048872613517359.Khanna S, Bhat A, Chen HH, et al. Left Ventricular Sphericity Index is a reproducible bedside echocardiographic measure of geometric change between acute phase Takotsubo’s syndrome and acute anterior myocardial infarction. Int J Cardiol Heart Vasc. 2020;29:100547. doi:10.1016/j.ijcha.2020.100547.Khanna S, Bhat A, Chen HH, et al. Left Ventricular Sphericity Index is a reproducible bedside echocardiographic measure of geometric change between acute phase Takotsubo’s syndrome and acute anterior myocardial infarction. Int J Cardiol Heart Vasc. 2020;29:100547. doi:10.1016/j.ijcha.2020.100547.Scally C, Rudd A, Mezincescu A, et al. Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy. Circulation. 2018;137:1039-48. doi:10.1161/CIRCULATIONAHA.117.031841.Scally C, Rudd A, Mezincescu A, et al. Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy. Circulation. 2018;137:1039-48. doi:10.1161/CIRCULATIONAHA.117.031841.Schwarz K, Ahearn T, Srinivasan J, et al. Alterations in Cardiac Deformation, Timing of Contraction and Relaxation, and Early Myocardial Fibrosis Accompany the Apparent Recovery of Acute Stress-Induced (Takotsubo) Cardiomyopathy: An End to the Concept of Transience. J. Am. Soc. Echocardiogr. 2017;30:745-55. doi:10.1016/j.echo.2017.03.016.Schwarz K, Ahearn T, Srinivasan J, et al. Alterations in Cardiac Deformation, Timing of Contraction and Relaxation, and Early Myocardial Fibrosis Accompany the Apparent Recovery of Acute Stress-Induced (Takotsubo) Cardiomyopathy: An End to the Concept of Transience. J. Am. Soc. Echocardiogr. 2017;30:745-55. doi:10.1016/j.echo.2017.03.016.Alashi A, Isaza N, Faulx J, et al. Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function. J Am Heart Assoc. 2020;9(16):e016537. doi:10.1161/JAHA.120.016537.Alashi A, Isaza N, Faulx J, et al. Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function. J Am Heart Assoc. 2020;9(16):e016537. doi:10.1161/JAHA.120.016537.Subbaraman S, Rajan SC, Veeraiyan S, Natarajan P. Takotsubo Cardiomyopathy: Role of Cardiac MRI. J Radiol Case Rep. 2021;15(6):26-32. doi:10.3941/jrcr.v15i6.4138.Subbaraman S, Rajan SC, Veeraiyan S, Natarajan P. Takotsubo Cardiomyopathy: Role of Cardiac MRI. J Radiol Case Rep. 2021;15(6):26-32. doi:10.3941/jrcr.v15i6.4138.Tamis-Holland JE, Jneid H, Reynolds HR, et al. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019;139(18):891-908. doi:10.1161/CIR.0000000000000670.Tamis-Holland JE, Jneid H, Reynolds HR, et al. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019;139(18):891-908. doi:10.1161/CIR.0000000000000670.Palmisano A, Vignale D, Tadic M, et al. Myocardial Late Contrast Enhancement CT in Troponin-Positive Acute Chest Pain Syndrome. Radiology. 2021;211288. doi:10.1148/radiol.211288.Palmisano A, Vignale D, Tadic M, et al. Myocardial Late Contrast Enhancement CT in Troponin-Positive Acute Chest Pain Syndrome. Radiology. 2021;211288. doi:10.1148/radiol.211288.Schuster A, Hor KN, Kowallick JT, et al. Cardiovascular Magnetic Resonance Myocardial Feature Tracking. Circ. Cardiovasc. Imaging. 2016;9:e004077. doi:10.1161/CIRCIMAGING.115.004077.Schuster A, Hor KN, Kowallick JT, et al. Cardiovascular Magnetic Resonance Myocardial Feature Tracking. Circ. Cardiovasc. Imaging. 2016;9:e004077. doi:10.1161/CIRCIMAGING.115.004077.Backhaus SJ, Stiermaier T, Lange T, et al. Temporal changes within mechanical dyssynchrony and rotational mechanics in Takotsubo syndrome: A cardiovascular magnetic resonance imaging study. Int. J. Cardiol. 2018;273:256-62. doi:10.1016/j.ijcard.2018.04.088.Backhaus SJ, Stiermaier T, Lange T, et al. Temporal changes within mechanical dyssynchrony and rotational mechanics in Takotsubo syndrome: A cardiovascular magnetic resonance imaging study. Int. J. Cardiol. 2018;273:256-62. doi:10.1016/j.ijcard.2018.04.088.Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-367. doi:10.1093/eurheartj/ehaa575.Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289-367. doi:10.1093/eurheartj/ehaa575.Santoro F, Núñez Gil IJ, Stiermaier T, et al. Assessment of the German and Italian Stress Cardiomyopathy Score for Risk Stratification for In-hospital Complications in Patients with Takotsubo Syndrome. JAMA Cardiol. 2019;4:892-9. doi:10.1001/jamacardio.2019.2597.Santoro F, Núñez Gil IJ, Stiermaier T, et al. Assessment of the German and Italian Stress Cardiomyopathy Score for Risk Stratification for In-hospital Complications in Patients with Takotsubo Syndrome. JAMA Cardiol. 2019;4:892-9. doi:10.1001/jamacardio.2019.2597.Santoro F, Mallardi A, Leopizzi A, et al. Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 2-Treatment and Prognosis. J Clin Med. 2021;10(3):468. doi:10.3390/jcm10030468.Santoro F, Mallardi A, Leopizzi A, et al. Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 2-Treatment and Prognosis. J Clin Med. 2021;10(3):468. doi:10.3390/jcm10030468.Santoro F, Ieva R, Musaico F, et al. Lack of efficacy of drug therapy in preventing Takotsubo cardiomyopathy recurrence: A meta-analysis. Clin. Cardiol. 2014;37:434-9. doi:10.1002/clc.22280.Santoro F, Ieva R, Musaico F, et al. Lack of efficacy of drug therapy in preventing Takotsubo cardiomyopathy recurrence: A meta-analysis. Clin. Cardiol. 2014;37:434-9. doi:10.1002/clc.22280.Almendro-Delia M, Núñez-Gil IJ, Lobo M, et al. Short- and Long-Term Prognostic Relevance of Cardiogenic Shock in Takotsubo Syndrome: Results from the RETAKO Registry. JACC Heart Fail. 2018;6:928-36. doi:10.1016/j.jchf.2018.05.015.Almendro-Delia M, Núñez-Gil IJ, Lobo M, et al. Short- and Long-Term Prognostic Relevance of Cardiogenic Shock in Takotsubo Syndrome: Results from the RETAKO Registry. JACC Heart Fail. 2018;6:928-36. doi:10.1016/j.jchf.2018.05.015.Ansari U, El-Battrawy I, Fastner C, et al. Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy. BMC Cardiovasc. Disord. 2018;18:54. doi:10.1186/s12872-018-0784-6.Ansari U, El-Battrawy I, Fastner C, et al. Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy. BMC Cardiovasc. Disord. 2018;18:54. doi:10.1186/s12872-018-0784-6.Dias A, Núñez Gil IJ, Santoro F, et al. Takotsubo syndrome: State-of-the-art review by an expert panel — Part 2. Cardiovasc. Revasc. Med. 2019;20:153-66. doi:10.1016/j.carrev.2018.11.016.Dias A, Núñez Gil IJ, Santoro F, et al. Takotsubo syndrome: State-of-the-art review by an expert panel — Part 2. Cardiovasc. Revasc. Med. 2019;20:153-66. doi:10.1016/j.carrev.2018.11.016.Gili S, Cammann VL, Schlossbauer SA, et al. Cardiac arrest in takotsubo syndrome: Results from the InterTAK Registry. Eur. Heart J. 2019;40:2142-51. doi:10.1093/eurheartj/ehz170.Gili S, Cammann VL, Schlossbauer SA, et al. Cardiac arrest in takotsubo syndrome: Results from the InterTAK Registry. Eur. Heart J. 2019;40:2142-51. doi:10.1093/eurheartj/ehz170.Kosmas N, Manolis AS, Dagres N, Iliodromitis EK. Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connection. Europace. 2020;22( 9):1303-10. doi:10.1093/europace/euaa156.Kosmas N, Manolis AS, Dagres N, Iliodromitis EK. Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connection. Europace. 2020;22( 9):1303-10. doi:10.1093/europace/euaa156.El-Battrawy I, Santoro F, Stiermaier T, et al. Prevalence, management, and outcome of adverse rhythm disorders in takotsubo syndrome: Insights from the international multicenter GEIST registry. Heart Fail Rev. 2020;25:505-11. doi:10.1007/s10741-019-09856-4.El-Battrawy I, Santoro F, Stiermaier T, et al. Prevalence, management, and outcome of adverse rhythm disorders in takotsubo syndrome: Insights from the international multicenter GEIST registry. Heart Fail Rev. 2020;25:505-11. doi:10.1007/s10741-019-09856-4.El-Battrawy I, Erath JW, Lang S, et al. Takotsubo syndrome and cardiac implantable electronic device therapy. Sci. Rep. 2019;9:16559. doi:10.1038/s41598-019-52929-5.El-Battrawy I, Erath JW, Lang S, et al. Takotsubo syndrome and cardiac implantable electronic device therapy. Sci. Rep. 2019;9:16559. doi:10.1038/s41598-019-52929-5.Santoro F, Stiermaier T, Tarantino N, et al. Left ventricular thrombi in Takotsubo syndrome: Incidence, predictors, and management: Results from the GEIST (German Italian Stress Cardiomyopathy) Registry. J. Am. Heart Assoc. 2017;6:e006990. doi:10.1161/JAHA.117.006990.Santoro F, Stiermaier T, Tarantino N, et al. Left ventricular thrombi in Takotsubo syndrome: Incidence, predictors, and management: Results from the GEIST (German Italian Stress Cardiomyopathy) Registry. J. Am. Heart Assoc. 2017;6:e006990. doi:10.1161/JAHA.117.006990.Sattar Y, Siew KSW, Connerney M, et al. Management of Takotsubo Syndrome: A Comprehensive Review. Cureus. 2020;12(1):e6556. doi:10.7759/cureus.6556.Sattar Y, Siew KSW, Connerney M, et al. Management of Takotsubo Syndrome: A Comprehensive Review. Cureus. 2020;12(1):e6556. doi:10.7759/cureus.6556.Ding KJ, Cammann VL, Szawan KA, et al. Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome: Insights From the International Takotsubo Registry. Arter. Thromb. Vasc. Biol. 2020;40:279-87. doi:10.1161/ATVBAHA.119.313491.Ding KJ, Cammann VL, Szawan KA, et al. Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome: Insights From the International Takotsubo Registry. Arter. Thromb. Vasc. Biol. 2020;40:279-87. doi:10.1161/ATVBAHA.119.313491.Hovgaard HL, Zaremba T, Aaroe J. Relapsing Classical Takotsubo Syndrome in a Postmenopausal Woman Successfully Managed with Psychology Consultations. Cureus. 2019;11:e5361. doi:10.7759/cureus.5361.Hovgaard HL, Zaremba T, Aaroe J. Relapsing Classical Takotsubo Syndrome in a Postmenopausal Woman Successfully Managed with Psychology Consultations. Cureus. 2019;11:e5361. doi:10.7759/cureus.5361.Lu X, Li P, Teng C, et al. Prognostic factors of Takotsubo cardiomyopathy: a systematic review. ESC Heart Fail. 2021;8(5):3663-89. doi:10.1002/ehf2.13531.Lu X, Li P, Teng C, et al. Prognostic factors of Takotsubo cardiomyopathy: a systematic review. ESC Heart Fail. 2021;8(5):3663-89. doi:10.1002/ehf2.13531.Singh K, Carson K, Usmani Z, et al. Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathy. Int J Cardiol. 2014;174(3):696-701. doi:10.1016/j.ijcard.2014.04.221.Singh K, Carson K, Usmani Z, et al. Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathy. Int J Cardiol. 2014;174(3):696-701. doi:10.1016/j.ijcard.2014.04.221.Lau C, Chiu S, Nayak R, et al. Survival and risk of recurrence of takotsubo syndrome. Heart. 2021;107(14):1160-6. doi:10.1136/heartjnl-2020-318028.Lau C, Chiu S, Nayak R, et al. Survival and risk of recurrence of takotsubo syndrome. Heart. 2021;107(14):1160-6. doi:10.1136/heartjnl-2020-318028.Rizzetto F, Lia M, Widmann M, et al. Prognostic impact of antiplatelet therapy in Takotsubo syndrome: a systematic review and meta-analysis of the literature. Heart Fail Rev. 2021. doi:10.1007/s10741-021-10099-5.Rizzetto F, Lia M, Widmann M, et al. Prognostic impact of antiplatelet therapy in Takotsubo syndrome: a systematic review and meta-analysis of the literature. Heart Fail Rev. 2021. doi:10.1007/s10741-021-10099-5.D’Ascenzo F, Gili S, Bertaina M, et al. Impact of aspirin on takotsubo syndrome: A propensity score-based analysis of the InterTAK Registry. Eur. J. Heart Fail. 2020;22:330-7. doi:10.1002/ejhf.1698.D’Ascenzo F, Gili S, Bertaina M, et al. Impact of aspirin on takotsubo syndrome: A propensity score-based analysis of the InterTAK Registry. Eur. J. Heart Fail. 2020;22:330-7. doi:10.1002/ejhf.1698.Elesber AA, Prasad A, Lennon RJ, et al. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007;50(5):448-52. doi:10.1016/j.jacc.2007.03.050.Elesber AA, Prasad A, Lennon RJ, et al. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007;50(5):448-52. doi:10.1016/j.jacc.2007.03.050.El-Battrawy I, Santoro F, Stiermaier T, et al. Incidence and Clinical Impact of Recurrent Takotsubo Syndrome: Results From the GEIST Registry. J. Am. Heart Assoc. 2019;8:e010753. doi:10.1161/JAHA.118.010753.El-Battrawy I, Santoro F, Stiermaier T, et al. Incidence and Clinical Impact of Recurrent Takotsubo Syndrome: Results From the GEIST Registry. J. Am. Heart Assoc. 2019;8:e010753. doi:10.1161/JAHA.118.010753.Ghadri JR, Kato K, Cammann VL, et al. Long-Term Prognosis of Patients With Takotsubo Syndrome. J Am Coll Cardiol. 2018;72(8):874-82. doi:10.1016/j.jacc.2018.06.016.Ghadri JR, Kato K, Cammann VL, et al. Long-Term Prognosis of Patients With Takotsubo Syndrome. J Am Coll Cardiol. 2018;72(8):874-82. doi:10.1016/j.jacc.2018.06.016.Uribarri A, Núñez-Gil IJ, Conty DA, et al. Short- and Long-Term Prognosis of Patients with Takotsubo Syndrome Based on Different Triggers: Importance of the Physical Nature.J. Am. Heart Assoc. 2019;8:e013701. doi:10.1161/JAHA.119.013701.Uribarri A, Núñez-Gil IJ, Conty DA, et al. Short- and Long-Term Prognosis of Patients with Takotsubo Syndrome Based on Different Triggers: Importance of the Physical Nature.J. Am. Heart Assoc. 2019;8:e013701. doi:10.1161/JAHA.119.013701.

The authors declare that there are no conflicts of interest present.